Early Termination of Oncology Clinical Trials in the United States

por Zhang, Ellen, DuBois, Steven G.
Publicado 2022

Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma

por Vo, Kieuhoa T., Matthay, Katherine K., DuBois, Steven G.
Publicado 2016

Population pharmacokinetics–pharmacodynamics of sunitinib in pediatric patients with solid tumors

por Wang, Erjian, DuBois, Steven G., Wetmore, Cynthia, Khosravan, Reza
Publicado 2020

Extrapolation of pharmacokinetics and pharmacodynamics of sunitinib in children with gastrointestinal stromal tumors

por Khosravan, Reza, DuBois, Steven G., Janeway, Katherine, Wang, Erjian
Publicado 2021

Comparison of Epidemiology, Clinical Features, and Outcomes of Patients with Reported Ewing Sarcoma and PNET over 40 Years Justifies Current WHO Classification and Treatment Approa...

por Campbell, Kevin, Shulman, David, Janeway, Katherine A., DuBois, Steven G.
Publicado 2018

Clinical Characteristics and Outcomes of Pediatric Patients with Desmoplastic Small Round Cell Tumor

por Bent, Melissa A., Padilla, Benjamin E., Goldsby, Robert E., DuBois, Steven G.
Publicado 2016

Sponsorship of oncology clinical trials in the United States according to age of eligibility

por Neel, Dylan V., Shulman, David S., Ma, Clement, Bourgeois, Florence, DuBois, Steven G.
Publicado 2020

Population Pharmacokinetics of Sunitinib and its Active Metabolite SU012662 in Pediatric Patients with Gastrointestinal Stromal Tumors or Other Solid Tumors

por Wang, Erjian, DuBois, Steven G., Wetmore, Cynthia, Verschuur, Arnauld C., Khosravan, Reza
Publicado 2021

Clinical Features and Outcomes Differ between Skeletal and Extraskeletal Osteosarcoma

por Thampi, Sheila, Matthay, Katherine K., Boscardin, W. John, Goldsby, Robert, DuBois, Steven G.
Publicado 2014

Phase I/II study of (131)I-MIBG with vincristine and 5 days of irinotecan for advanced neuroblastoma

por DuBois, S G, Allen, S, Bent, M, Hilton, J F, Hollinger, F, Hawkins, R, Courtier, J, Mosse, Y P, Matthay, K K
Publicado 2015

Off‐label prescribing of targeted anticancer therapy at a large pediatric cancer center

por Lim, Mir, Shulman, David S., Roberts, Holly, Li, Anran, Clymer, Jessica, Bona, Kira, Al‐Sayegh, Hasan, Ma, Clement, DuBois, Steven G.
Publicado 2020

Correlation of Ezrin Expression Pattern and Clinical Outcomes in Ewing Sarcoma

por Cash, Thomas, Yin, Hong, McCracken, Courtney, Geng, Zhi, DuBois, Steven G., Shehata, Bahig M., Olson, Thomas A., Katzenstein, Howard M., Wetmore, Cynthia
Publicado 2017

Superselective intra-arterial melphalan therapy for newly diagnosed and refractory retinoblastoma: results from a single institution

por Thampi, Sheila, Hetts, Steven W, Cooke, Daniel L, Stewart, Paul J, Robbins, Elizabeth, Banerjee, Anuradha, DuBois, Steven G, Char, Devron, Halbach, Van, Matthay, Katherine
Publicado 2013

Phase 1 study of sirolimus in combination with oral cyclophosphamide and topotecan in children and young adults with relapsed and refractory solid tumors

por Vo, Kieuhoa T., Karski, Erin E., Nasholm, Nicole M., Allen, Shelly, Hollinger, Fabienne, Clay Gustafson, W., Long-Boyle, Janel R., Shiboski, Stephen, Matthay, Katherine K., DuBois, Steven G.
Publicado 2016

Genetic susceptibility to bone and soft tissue sarcomas: a field synopsis and meta-analysis

por Benna, Clara, Simioni, Andrea, Pasquali, Sandro, De Boni, Davide, Rajendran, Senthilkumar, Spiro, Giovanna, Colombo, Chiara, Virgone, Calogero, DuBois, Steven G., Gronchi, Alessandro, Rossi, Carlo Riccardo, Mocellin, Simone
Publicado 2018

A phase 1 study of oral ridaforolimus in pediatric patients with advanced solid tumors

por Pearson, Andrew D.J., Federico, Sara M., Aerts, Isabelle, Hargrave, Darren R., DuBois, Steven G., Iannone, Robert, Geschwindt, Ryan D., Wang, Ruixue, Haluska, Frank G., Trippett, Tanya M., Geoerger, Birgit
Publicado 2016

Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children’s Oncology Group

por Shulman, David S., Chen, Sonja, Hall, David, Nag, Anwesha, Thorner, Aaron R., Lessnick, Stephen L., Stegmaier, Kimberly, Janeway, Katherine A., DuBois, Steven G., Krailo, Mark D., Barkauskas, Donald A., Church, Alanna J., Crompton, Brian D.
Publicado 2022

Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma

por Shulman, David S., Merriam, Priscilla, Choy, Edwin, Guenther, Lillian M., Cavanaugh, Kerri L., Kao, Pei‐Chi, Posner, Andrew, Bhushan, Ketki, Fairchild, Grace, Barker, Emma, Klega, Kelly, Stegmaier, Kimberly, Crompton, Brian D., London, Wendy B., DuBois, Steven G.
Publicado 2023

An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients

por Chau, Nicole G, Ma, Clement, Danga, Kristina, Al-Sayegh, Hasan, Nardi, Valentina, Barrette, Ryan, Lathan, Christopher S, DuBois, Steven G, Haddad, Robert I, Shapiro, Geoffrey I, Sallan, Stephen E, Dhar, Arindam, Nelson, Jeanenne J, French, Christopher A
Publicado 2019

The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute

por Tolaney, Sara M, Lydon, Christine A, Li, Tianyu, Dai, Jiale, Standring, Andrea, Legor, Kristen A, Caparrotta, Caryn M, Schenker, Matthew P, Glazer, Daniel I, Tayob, Nabihah, DuBois, Steven G, Meyerhardt, Jeffrey A, Taplin, Mary-Ellen, Johnson, Bruce E
Publicado 2020